NCT03898154 Perioperative Glucocorticoid Administration in the Treatment of Adult Distal Radius Fractures Status TERMINATED Phase PHASE4
NCT03892421 Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03891355 Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL Status UNKNOWN Phase PHASE2
NCT03877549 Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery Status WITHDRAWN Phase PHASE4
NCT03863977 Post-operative Analgesic Effects of Dexamethasone Added to Bupivacaine in Transversusabdominis Plane (TAP) Block Status COMPLETED Phase PHASE2/PHASE3
NCT03859427 A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT03859024 Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty Status COMPLETED Phase PHASE4
NCT03856112 Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE1/PHASE2
NCT03841565 Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT03839940 Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer Status TERMINATED Phase PHASE3
NCT03837873 DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma Status UNKNOWN Phase PHASE2
NCT03834506 Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) Status COMPLETED Phase PHASE3
NCT03829371 STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03828292 An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments Status COMPLETED Phase PHASE1
NCT03817320 PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03815279 A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT03809780 Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone Status ACTIVE_NOT_RECRUITING Phase PHASE2